2003International Journal of Radiation Oncology*Biology*PhysicsRequires access

Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial

Helen Athanassiou, Dosia Antonadou, Nikos Coliarakis, Athina Kouveli, Maria Synodinou, M. Paraskevaidis, George E. Sarris, Gregory R Georgakopoulos, Katerina Panousaki, Pantelis Karageorgis, Nicolas Throuvalas

Open publisher page 119 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 119 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Amifostine, Medicine, Randomized controlled trial, Urology, Nausea, Radiation therapy, Pelvis, Toxicity

Related papers

Back to paper searchBrowse research topicsOriginal source
Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial — Research Paper | ScholarLens